B7-mediated costimulation and the immune response (Q41116012)

27 September 2017

1 reference

title

B7-mediated costimulation and the immune response (English)

1 reference

27 September 2017

1 reference

27 September 2017

Nadler LM

1 reference

27 September 2017

Gribben JG

1 reference

27 September 2017

publication date

1 June 1996

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

page(s)

111-127

1 reference

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

B70 antigen is a second ligand for CTLA-4 and CD28

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

A new member of the immunoglobulin superfamily--CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CTLA-4 is a second receptor for the B cell activation antigen B7

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Reversal of in vitro T cell clonal anergy by IL-2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Differential T cell costimulatory requirements in CD28-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Expression of the B7/BB1 Activation Antigen and its Ligand CD28 in T-Cell-Mediated Skin Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Tumor immunotherapy: the tumor cell as an antigen-presenting cell

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

A new look for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Costimulation of T cells for tumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

CD40-CD40 ligand interactions stimulate B cell antigen processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Identifying strategies for immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

T‐Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2896%2990040-5

7 January 2021

10.1016/S0268-960X(96)90040-5

Identifiers

DOI

1 reference

27 September 2017

1 reference